SCHEMBL8324231

SCHEMBL8324231

CCOc1ccc(C(=O)Cl)c2c3c(oc12)CCCC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
KDM4E B2RXH2 6/20 0.43
HPGD P15428 4/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
HSD17B10 Q99714 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TP53 P04637 1/20 0.36
CA9 Q16790 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
FHIT P49789 2/20 0.35
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
NPC1 O15118 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921360 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL8319163 0.86 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL8320953 0.85 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL8324499 0.84 CNR2 (0.35)
SCHEMBL8323847 0.82 TSHR (0.37) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL8325988 0.80 PDE4D (0.35) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL8324502 0.79 PDE4A (0.33)
SCHEMBL8318915 0.76 NPC1 (0.50) ALDH1A1KDM4ESMN1; SMN2MAPTTP53
SCHEMBL8325518 0.70 MAPT (0.38) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL11369549 0.66 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 WO disclosed